September 25, 2021

The Indie Toaster

Complete News World

Uruguay: Vaccines reduce mortality and hospitalization by more than 90% – News

Intensive treatment combination and mortality Govit-19 More than 90% of Uruguay’s civilians who took two drugs, Coronavac and Pfizer, were reduced, according to a report released by the government on Tuesday (8).

Also read: Uruguay will vaccinate young people between the ages of 12 and 18 against Covit-19

With a population of 3.5 million, the country has a successful vaccination campaign, leading in Chile with South America. It has the highest death toll in the world at over one million.

According to the Ministry of Public Health, approximately 52% of the population received a single dose of the Covit-19 vaccine, and as of June 1, 29% had been vaccinated with two doses of the immunizing agent. The results of the report include individuals who have been vaccinated in both doses, more than 14 days after the last application.

Regarding the coronavac vaccine developed by the Chinese pharmacist Sinovac Biotech, the study found that “the effectiveness of reducing the incidence in all subgroups exceeded 61%; the reduction in admission to the intensive care unit (ICU) was more than 92%, and the reduction in morbidity and mortality was more than 95%. it is too much “.

Coronavac’s subgroups correspond to populations ranging in age from 18 to 49 and between 50 and 69 years.

Regarding the vaccine developed by Pfizer / Bioendech, the document states that “the percentage of efficacy in reducing the incidence is more than 78%, the adaptation to ICU is more than 94% in reducing and the mortality is more than 94% in preventing.” PFLser’s vaccine is designed for people 80 years of age and older and health professionals.

See also  Why Australia is abandoning the zero Govt strategy